Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
semaglutide
Fierce Pharma
Novo Nordisk’s ‘optimistic’ CEO Doustdar sits down with Fierce
Novo Nordisk CEO Mike Doustdar told Fierce in an interview that he always believed the Big Pharma “did actually need to become more competitive.”
Fraiser Kansteiner
Jun 11, 2026 7:00am
ADA: Novo CSO says ‘jury still out’ on CagriSema v. retatrutide
Jun 10, 2026 11:10am
GLP-1s may combat depression through a mood-boosting gut microbe
Jun 10, 2026 11:00am
How GLP-1s help the heart relax: study
Mar 2, 2026 7:01pm
Novo's CagriSema loses phase 3 obesity battle against Zepbound
Feb 23, 2026 7:20am
Novo’s CagriSema tops semaglutide in ph. 3 diabetes study
Feb 2, 2026 3:01pm
